"Le Centre Antoine Lacassagne est multi-sites, nous vous invitons à bien vérifier l’adresse de votre rdv."

During the past decade, Centre Antoine Lacassagne; Hopital De Jour A2 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Antoine Lacassagne; Hopital De Jour A2" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centre Antoine Lacassagne; Hopital De Jour A2" are "Breast Cancer" (7 trials), "Ovarian Cancer" (3 trials), "Colorectal Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Rectal Cancer" (1 trials). Many other conditions were trialed in "Centre Antoine Lacassagne; Hopital De Jour A2" in a lesser frequency.

Most popular intervention types in "Centre Antoine Lacassagne; Hopital De Jour A2" are "Drug" (12 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (7 trials), "Bevacizumab" (5 trials), "Pertuzumab" (5 trials), "Docetaxel" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centre Antoine Lacassagne; Hopital De Jour A2" are 7 trials for "Female" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Centre Antoine Lacassagne; Hopital De Jour A2". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centre Antoine Lacassagne; Hopital De Jour A2, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Antoine Lacassagne; Hopital De Jour A2, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".